![](/img/cover-not-exists.png)
Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
Chiyoe Kitagawa, Hideo Saka, Shigehisa Kajikawa, Kouki Mori, Masahide Oki, Ryujiro SuzukiVolume:
69
Language:
english
Pages:
7
DOI:
10.1007/s00280-011-1812-8
Date:
May, 2012
File:
PDF, 301 KB
english, 2012